Advances in Xenotransplantation and Bioengineered Kidneys for Overcoming Organ Shortage

Abstract

The global burden of end-stage renal disease continues to increase and the availability of suitable donor kidneys remains critically insufficient. This extended gap between supply and demand has enhanced the significant research interest in alternative strategies for kidney replacement. Xenotransplantation techniques using genetically modified porcine donors has progressed remarkably due to advances in genome editing tools such as CRISPR-Cas9. It enables precise modification of donor animals to minimize hyperacute rejection and improve graft compatibility. Breakthroughs in immune tolerance induction, including targeted deletion of xenoantigens and introduction of human complement regulatory genes have transformed the feasibility of cross-species transplantation. Meanwhile, bioengineered kidneys derived through regenerative medicine approaches includes decellularized scaffolds, stem cell- erived renal organoids, 3D bioprinting, and biomimetic extracellular matrices. It offers a promising pathway toward personalized organ replacement. These technologies aim to recreate functional nephron structures capable of filtration, reabsorption, and endocrine regulation while ensuring biocompatibility and long-term stability. Furthermore, integration of microfluidic platforms and organ-on-chip systems has enhanced preclinical testing which accelerates the translation of engineered tissues into clinical evaluation. Despite these advances, significant challenges includes incomplete vascularization, immune complications, ethical considerations, and limited large-scale manufacturing capacity. Continued interdisciplinary collaboration is essential to overcome these obstacles. Collectively, innovations in xenotransplantation and bioengineered kidney development hold transformative potential to alleviate global organ shortages and pave the way for sustainable and patient-specific renal replacement therapies.